RecruitingPhase 3NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Sponsor: Zenas BioPharma (USA), LLC
Cordova, TN · +18 more sites
Clinical trials in Cordova, TN
20 recruiting studies have a site in or near Cordova, TN, Tennessee.
Top conditions here
- Ulcerative Colitis (6)
- Crohn's Disease (4)
- Multiple Sclerosis (4)
- Alzheimer's Disease (4)
- Obesity (2)
- Parkinson's Disease (1)
- Schizophrenia (1)
- Colorectal Cancer (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 20 of 20 studies
RecruitingPhase 3NCT07577843
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Janssen Research & Development, LLC
Cordova, TN · +21 more sites
RecruitingPhase 3NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Cordova, TN · Nashville, TN · +41 more sites
RecruitingPhase 3NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Janssen Research & Development, LLC
Cordova, TN · +23 more sites
RecruitingPhase 2NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Sponsor: Eli Lilly and Company
Cordova, TN · +39 more sites
RecruitingPhase 3NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Sponsor: Eli Lilly and Company
Cordova, TN · +36 more sites
RecruitingPhase 3NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Sponsor: Eli Lilly and Company
Cordova, TN · +34 more sites
RecruitingPhase 3NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Sponsor: Zenas BioPharma (USA), LLC
Cordova, TN · +25 more sites
RecruitingPhase 2NCT06808984
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Sponsor: Celgene
Chattanooga, TN · Cordova, TN · Nashville, TN · +57 more sites
RecruitingPhase 3NCT06976216
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Sponsor: Bristol-Myers Squibb
Cordova, TN · +27 more sites
RecruitingPhase 4NCT07609719
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Sponsor: Genentech, Inc.
Cordova, TN · +3 more sites
RecruitingPhase 1 / Phase 2NCT06619990
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Sponsor: Xencor, Inc.
Cordova, TN · +29 more sites
RecruitingPhase 2NCT07845487
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Palisade Bio
Cordova, TN · +29 more sites
RecruitingPhase 3NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Hoffmann-La Roche
Cordova, TN · Nashville, TN · +59 more sites
RecruitingPhase 4NCT07633470
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Sponsor: Alpha Cognition, Inc
Cordova, TN · +19 more sites
RecruitingPhase 2 / Phase 3NCT07284784
A Study of Buntanetap in Participants With PD
Sponsor: Annovis Bio Inc.
Cordova, TN · Memphis, TN · +25 more sites
RecruitingPhase 1 / Phase 2NCT07599670
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
Sponsor: AbbVie
Cordova, TN · +10 more sites
RecruitingPhase not listedNCT07379827
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Sponsor: Bristol-Myers Squibb
Cordova, TN · Franklin, TN · +53 more sites
RecruitingPhase 1 / Phase 2NCT05552755
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
Sponsor: Recursion Pharmaceuticals Inc.
Cordova, TN · Nashville, TN · +15 more sites
RecruitingPhase 2NCT07113522
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Sponsor: Mirador Therapeutics, Inc.
Cordova, TN · +45 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.